We can wish but that is not reality. The current RETT trial is adult. So maybe not approval for the children until they complete a pediatric trial. However if they prove the efficacy in Adult maybe a safety trial in children that would be quick with possible provisional use until full approval. However the market may price in eventual approval into AVXL stock price on strong results in Adult RETT. After all they have less than nothing now.
News 
Market Data 
Discover 
AI
